Concepedia

Jin-Kai Feng

JF

Statistics

Publications

12

Citations

298

H-Index

11

Active since

2021

Affiliations

Eastern Hepatobiliary Surgery Hospital(Current)

Second Military Medical University

First Affiliated Hospital of Wenzhou Medical University

Chinese University of Hong Kong

Wenzhou Medical University

Jin-Kai Feng is an author at Eastern Hepatobiliary Surgery Hospital specializing in oncology, medicine, and hepatocellular carcinoma treatment.

ORCID

Publications per year

2021–2024

12

Publications

12

Actual long-term survival in hepatocellular carcinoma patients with microvascular invasion: a multicenter study from China

Zhenhua Chen, Xiuping Zhang, Jin-Kai Feng et al. · Hepatology International · 2021 · 55 citations

, , +17

Transarterial chemoembolization plus a PD‐1 inhibitor with or without lenvatinib for intermediate‐stage hepatocellular carcinoma

Yan‐Jun Xiang, Kang Wang, Hongming Yu et al. · Hepatology Research · 2022 · 42 citations

, , +16

Patterns, treatments, and prognosis of tumor recurrence after resection for hepatocellular carcinoma with microvascular invasion: a multicenter study from China

Zhenhua Chen, Xiuping Zhang, Jin-Kai Feng et al. · HPB · 2021 · 35 citations · Full text

, , +17

Efficacy and safety of <scp>TACE</scp> combined with lenvatinib and <scp>PD</scp>‐1 inhibitors for unresectable recurrent <scp>HCC</scp>: A multicenter, retrospective study

Weijun Wang, Zong‐Han Liu, Kang Wang et al. · Cancer Medicine · 2023 · 34 citations · Full text

, , +10

Effects of Stereotactic Body Radiation Therapy Plus PD-1 Inhibitors for Patients With Transarterial Chemoembolization Refractory

Yan‐Jun Xiang, Kang Wang, Yitao Zheng et al. · Frontiers in Oncology · 2022 · 29 citations · Full text

, , +10

1–5 of 12